EUVIMEDEUVIMED entdecken
Crossref

Levocabastine ameliorates cyclophosphamide-induced nephrotoxicity in Swiss albino mice via NF-κB/cleaved caspase-3/TGF-β signaling pathways

Wasim Akram, Abul Kalam Najmi, M Mumtaz Alam, Syed Ehtaishamul Haque

Drug Research · 01.06.2025 · 75 (05) · 148-161

DOI: 10.1055/a-2552-2486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.06.2025. Verfasst von Wasim Akram und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. Hauptthemen laut MEDLINE: Cyclophosphamide, Kidney Diseases. Die Arbeit nennt 48 Literaturangaben. Gefördert von: ICMR-SRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophosphamide (CP) is a potent anticancer drug, but nephrotoxicity is one of the vital organ toxicities that it causes as a side effect. We tried to evaluate the nephroprotective effect of levocabastine (LEV) in CP-induced nephrotoxicity in Swiss albino mice. Mice were given CP 200 mg/kg, i.p., once on the 7th day. LEV (0.05 and 0.1 mg/kg, i.p.) and fenofibrate (FF) (80 mg/kg, p.o.) were given daily for 14 days. On the 15th day, animals were sacrificed and kidneys were removed for examination. The docking study showed significant binding of LEV and FF against TGF-β1, which is a prime target molecule involved in nephrotoxicity. CP 200 group showed nephrotoxicity in terms of oxidative stress, apoptosis, inflammation, and fibrosis as manifested by decreased levels of SOD, catalase, GSH, blood urea nitrogen/creatinine (BUN/Cr) ratio, and increased TBARS, nitrite, TNF-α, IL-6, TGF-β1, IL-1β, urea, uric acid, creatinine, and BUN. A decrease in body weight (BW) and an increase in kidney weight (KW) with an increased KW/BW ratio was also observed. Cleaved caspase-3 and NF-κB expression was also increased. Histopathological aberrations, like renal corpuscle damage, Bowman’s space widening, glomerulus, mesangium cell disintegration, atrophic podocytes, vacuolation, and fibrotic changes were also seen. LEV 0.1 and FF 80 significantly reversed these changes toward normal and showed nephroprotective potential. Thus, seeing the protective effect of LEV on CP-intoxicated mice, we conclude that LEV may be used as an adjuvant with CP in cancer, however, it needs more studies with the direct cancer model to confirm the claim.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideKidney DiseasesAnimalsMiceNF-kappa BSignal TransductionOxidative StressKidneyCaspase 3ApoptosisMaleTransforming Growth Factor beta1Transforming Growth Factor betaMolecular Docking SimulationFenofibrate

Substanzen

CyclophosphamideNF-kappa BCaspase 3Transforming Growth Factor beta1Transforming Growth Factor betaFenofibrate

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.

Förderung

  • ICMR-SRF

Zitieren

APA

Akram, W., Najmi, A. K., Alam, M. M., & Haque, S. E. (2025). Levocabastine ameliorates cyclophosphamide-induced nephrotoxicity in Swiss albino mice via NF-κB/cleaved caspase-3/TGF-β signaling pathways. Drug Research, 75(05), 148-161. https://doi.org/10.1055/a-2552-2486

Vancouver

Akram W, Najmi AK, Alam MM, Haque SE. Levocabastine ameliorates cyclophosphamide-induced nephrotoxicity in Swiss albino mice via NF-κB/cleaved caspase-3/TGF-β signaling pathways. Drug Research. 2025;75(05):148-161. doi:10.1055/a-2552-2486

BibTeX
@article{Akram2025,
  author = {Akram, Wasim and Najmi, Abul Kalam and Alam, M Mumtaz and Haque, Syed Ehtaishamul},
  title = {Levocabastine ameliorates cyclophosphamide-induced nephrotoxicity in Swiss albino mice via NF-κB/cleaved caspase-3/TGF-β signaling pathways},
  journal = {Drug Research},
  year = {2025},
  volume = {75},
  number = {05},
  pages = {148--161},
  doi = {10.1055/a-2552-2486}
}
Kostenlos starten →